Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

New Rheumatology Disease Research & Advice

Thomas R. Collins  |  Issue: February 2018  |  February 17, 2018

A trial on the IL-17A inhibitor, secu­kinumab, is the first of a biologic therapy in axSpA that includes patients who didn’t respond well to TNF inhibitors, Dr. Gensler noted. Patients showed a significantly greater response than placebo at 16 weeks, but some data suggest those with Crohn’s disease did worse on the drug than on placebo. IL-17A, she said, plays an important role in gut homeostasis.

She said that for now, she’d remain cautious with the drug in these patients, and her personal preference is to use 17A inhibitors only in those with axSpA who don’t have inflammatory bowel disease.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

She said it remains somewhat unclear whether using secukinumab in patients predisposed to gut inflammation will make their inflammatory disease worse. “Long-term data will help unravel this,” she said.

Meniscus Tear & Adhesive Capsulitis

Dr. Senter

Dr. Senter

Carlin Senter, MD, associate professor of medicine at orthopedics at UCSF, gave rheumatologists guidance on navigating sports medicine cases. For starters, when evaluating a patient for a possible meniscus tear, she prefers to get a positive finding on at least three out of four tests before sending a patient for a knee MRI: the joint line tenderness test, the McMurray, the Thessaly and the squat test. The sensitivity of each of these tests is fairly low, so positive findings on multiple tests will yield more accurate results, she said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The joint line tenderness test involves palpating between the femur and the tibia, looking for only joint line tenderness and not bony tenderness, which would instead indicate osteoarthritis (OA). The McMurray involves placing a hand over the patient’s knee with the knee flexed and turning the toes in and out. In the Thessaly, the patient stands on the affected knee, with their foot planted while rotating and the clinician looks for pain medially or laterally during the pivoting. On the squat test, the clinician simply looks for pain medially or laterally while the patient squats, holding on to the examiner if needed.

Dr. Senter commonly faces situations in which she must determine whether to recommend surgery for a patient with medial compartmental OA and a meniscus tear. Of the four most recent studies on this topic, three showed no significant difference between arthroscopic partial meniscectomy and physical therapy (PT) vs. PT alone.

One study limitation: The studies allowed crossover, and 30% of patients did switch from PT to surgery, she said. Crossing over was associated with a shorter duration of symptoms and a higher initial pain score.

Page: 1 2 3 4 5 6 7 8 9 10 11 12 | Single Page
Share: 

Filed under:Axial SpondyloarthritisMeeting ReportsOsteoarthritis and Bone DisordersRheumatoid ArthritisSystemic SclerosisVasculitis Tagged with:ACR/ARHP Annual Meetingadhesive capsulitisANCAaxial spondyloarthritis (SpA)diabetesDry eyeEthicslung diseasemeniscus surgeryOsteoarthritisRaynaud'sred eyeRheumatoid arthritisscleritisVasculitis

Related Articles

    Case Report: Hydralazine-Induced ANCA-Associated Vasculitis

    February 16, 2021

    Hydralazine has been in use as a treatment for hypertension, most notably in heart failure patients, since 1951.1 The drug is a known cause of autoimmune disease, most specifically hydralazine-induced lupus.  Hydralazine-induced lupus occurs in 7–13% of those taking the medication.2-4 It often presents with constitutional symptoms, arthritis/arthralgias, cutaneous lesions, sero­sitis, myalgias and/or hepatomegaly. Features…

    ACR Winter Rheumatology Symposium: Tips for ANCA Testing

    May 1, 2013

    How to select the correct testing method and interpret conflicting results from antineutrophil cytoplasmic antibody tests

    Figure 2: Renal Biopsy

    The Classification & Diagnosis of Granulomatosis with Polyangiitis

    August 16, 2018

    Based on the classification system developed by the Chapel Hill Consensus Conference, anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis is defined as a necrotizing vasculitis involving small vessels that is associated with myeloperoxidase (MPO) ANCA or proteinase 3 (PR3) ANCA and displays minimal immune deposits. The mechanism behind the pathogenesis of ANCA-associated vasculitis is not fully…

    Does MRI Differentiate Osteoarthritis and Meniscal Tear in Knee Pain?

    December 19, 2017

    When a young patient arrives at a clinic complaining of knee pain with clicking or popping, a meniscal tear is often the culprit. “In young [people], there’s a pretty classic presentation of meniscal tear, with clicking and other mechanical symptoms, because the tear rubs up against different tissues,” says Jeffrey Katz, MD, MSc, a rheumatologist…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences